Notice NOT-MH-20-054 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-20-220 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity is to solicit new Institutional Network Awards (U2C/TL1) to cultivate a highly integrated cohort of people and resources to accelerate kidney, urologic and hematologic research. To maximize integration and promote a true trainee community, Institutions are invited to submit a single, unified U2C/TL1 application to engage, recruit, prepare and sustain the next generation of kidney, urology, and hematology researchers. Applications covering a single metropolitan area are strongly encouraged (see Section III.3).

Notice NOT-MH-20-057 from the NIH Guide for Grants and Contracts

Notice NOT-MH-20-056 from the NIH Guide for Grants and Contracts

Notice NOT-OD-20-107 from the NIH Guide for Grants and Contracts

Notice NOT-NS-20-074 from the NIH Guide for Grants and Contracts

Notice NOT-HL-20-793 from the NIH Guide for Grants and Contracts

Notice NOT-CA-20-071 from the NIH Guide for Grants and Contracts

Notice NOT-HL-20-791 from the NIH Guide for Grants and Contracts

Notice NOT-ES-20-018 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AG-21-025 from the NIH Guide for Grants and Contracts. This Small Business (R43/R44) Funding Opportunity Announcement (FOA) seeks to encourage small business research and development (R and D) of tools and technologies to support individuals, families, and care partners of individuals with Alzheimer's disease (AD) and AD-related dementias (ADRD) in dealing with financial and estate-related activities and responsibilities, which are often challenging and expensive to address and manage successfully. Tools and technologies designed in response to this FOA should be accessible to and appropriate for use by diverse populations across the socioeconomic spectrum.

Notice NOT-AT-20-012 from the NIH Guide for Grants and Contracts

Notice NOT-HS-20-011 from the NIH Guide for Grants and Contracts

Notice NOT-OD-20-110 from the NIH Guide for Grants and Contracts

Notice NOT-AA-20-013 from the NIH Guide for Grants and Contracts

Notice NOT-DC-20-007 from the NIH Guide for Grants and Contracts

Notice NOT-OD-20-109 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-RM-20-013 from the NIH Guide for Grants and Contracts. The NIH Directors Transformative Research Award Program supports individual scientists or groups of scientists proposing groundbreaking, exceptionally innovative, original, and/or unconventional research with the potential to create new scientific paradigms, establish entirely new and improved clinical approaches, or develop transformative technologies. For the program to support the best possible researchers and research, applications are sought which reflect the full diversity of the research workforce. Individuals from diverse backgrounds and from the full spectrum of eligible institutions in all geographic locations are strongly encouraged to apply to this Funding Opportunity Announcement. In addition, applications in all topics relevant to the broad mission of NIH are welcome, including, but not limited to, topics in the behavioral, social, biomedical, applied, and formal sciences and topics that may involve basic, translational, or clinical research. No preliminary data are required. Projects must clearly demonstrate, based on the strength of the logic, a compelling potential to produce a major impact in a broad area of relevance to the NIH. The NIH Directors Transformative Research Award is a component of the High-Risk, High-Reward Research program of the NIH Common Fund.

Funding Opportunity RFA-RM-20-014 from the NIH Guide for Grants and Contracts. The NIH Director's Early Independence Award supports exceptional investigators who wish to pursue independent research essentially after completion of their terminal doctoral/research degree or end of post-graduate clinical training, thereby forgoing the traditional post-doctoral training period and accelerating their entry into an independent research career. For the program to support the best possible researchers and research, applications are sought which reflect the full diversity of the research workforce. Individuals from diverse backgrounds and from the full spectrum of eligible institutions in all geographic locations are strongly encouraged to apply to this Funding Opportunity Announcement. In addition, applications in all topics relevant to the broad mission of NIH are welcome, including, but not limited to, topics in the behavioral, social, biomedical, applied, and formal sciences and topics that may involve basic, translational, or clinical research. The NIH Director's Early Independence Award is a component of the High-Risk, High-Reward Research program of the NIH Common Fund.

Funding Opportunity RFA-RM-20-020 from the NIH Guide for Grants and Contracts. This FOA solicits applications responsive only to the COVID-19 public health emergency through support of the CARES Act. All other Transformative Research Award applications must be submitted in response to RFA-RM-20-013. The NIH Directors Transformative Research Award Program supports individual scientists or groups of scientists proposing groundbreaking, exceptionally innovative, original, and/or unconventional research with the potential to create new scientific paradigms, establish entirely new and improved clinical approaches, or develop transformative technologies. For the program to support the best possible researchers and research, applications are sought which reflect the full diversity of the nations research workforce. Individuals from diverse backgrounds and from the full spectrum of eligible institutions in all geographic locations are strongly encouraged to apply to this Funding Opportunity Announcement. No preliminary data are required. Projects must clearly demonstrate, based on the strength of the logic, a compelling potential to produce a major impact on SARS-CoV-2 prevention, preparation, or response. The NIH Directors Transformative Research Award is a component of the High-Risk, High-Reward Research (HRHR) Program of the NIH Common Fund. Due to the COVID-19 public health emergency, the Common Fund will dedicate funds provided by the CARES Act to support a total of 5-10 Transformative Research Awards (through this FOA) or Early Independence Awards (through RFA-RM-20-021) that bring new, innovative perspectives and approaches to the prevention of, preparation for, or response to coronavirus SARS-CoV-2, domestically or internationally. Any relevant area of coronavirus SARS-CoV-2 research is welcome, including behavioral/social science research, research on health disparities, novel therapeutics, and other related topics. As with all High-Risk, High-Reward Research program applications, innovation may be technological or conceptual.